Petra Krabisch
About
In The Last Decade
Petra Krabisch
29 papers receiving 185 citations
Peers
Comparison fields: 5 of 40
- Oncology 137
- Cancer Research 112
- Pulmonary and Respiratory Medicine 49
- Molecular Biology 18
- Genetics 17
Countries citing papers authored by Petra Krabisch
This map shows the geographic impact of Petra Krabisch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Krabisch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Krabisch more than expected).
Fields of papers citing papers by Petra Krabisch
This network shows the impact of papers produced by Petra Krabisch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Krabisch. The network helps show where Petra Krabisch may publish in the future.
Co-authorship network of co-authors of Petra Krabisch
This figure shows the co-authorship network connecting the top 25 collaborators of Petra Krabisch. A scholar is included among the top collaborators of Petra Krabisch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Krabisch. Petra Krabisch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 6 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 74 | |
| 8 | 0 | |
| 9 | 3 | |
| 10 | 1 | |
| 11 | 6 | |
| 12 | Prospective WSG phase III PlanB trial: Clinical outcome at 5 year follow up and impact of 21 Gene Recurrence Score result, central/local-pathological review of grade, ER, PR and Ki67 in HR+/HER2-high risk node-negative and -positive breast cancer | 5 |
| 13 | 1 | |
| 14 | 8 | |
| 15 | 35 | |
| 16 | 1 | |
| 17 | 6 | |
| 18 | 3 | |
| 19 | 4 | |
| 20 | [Presence and pathogenic significance of Clostridium perfringens type A in swine]. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.